Francois Collin

Title: Innovations by Francois Collin in Health Technology

Introduction

Francois Collin is an innovative inventor based in San Francisco, CA. He is currently associated with Clearnote Health, Inc. Although he has not yet been granted any patents, his work focuses on advancing health technology through novel methodologies. His contributions are particularly significant in the field of cancer diagnostics and monitoring.

Latest Patent Applications

Francois Collin has submitted several patent applications that showcase his innovative approaches. One of his latest applications is titled "Hydroxymethylation Analysis of Cell-Free Nucleic Acid Samples for Assigning Tissue of Origin, and Related Methods of Use." This method provides a probabilistic approach to assigning a tissue of origin to nucleic acids in samples, such as DNA from cell-free fluids obtained from human subjects. The process involves generating a hydroxymethylation profile for the sample DNA and comparing it against a reference dataset to identify the tissue of origin.

Another significant application is "Pancreatic Ductal Adenocarcinoma Evaluation Using Cell-Free DNA Hydroxymethylation Profile." This invention aims to identify patients likely to have pancreatic ductal adenocarcinoma (PDAC) and those at risk of developing it. The methods disclosed utilize hydroxymethylation biomarkers in conjunction with clinical parameters to correlate with the presence or risk of PDAC.

Conclusion

Francois Collin's work at Clearnote Health, Inc. represents a promising advancement in health technology, particularly in cancer diagnostics. His innovative patent applications reflect his commitment to improving patient outcomes through scientific research and development.